secwatch.observer — SEC 8-K summary
======================================

Issuer:     Ensysce Biosciences, Inc. (ENSC)
CIK:        0001716947
Form:       8-K
Filed at:   2023-08-28T23:59:59+00:00
Accession:  0001493152-23-030391
Event type: other_material
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Ensysce shareholders elect directors, approve share increase, ratify auditor at annual meeting
--------------------------------------------------------------------------------

- Class II directors Bob Gower and Curtis Rosebraugh elected with 222,281 and 223,255 votes for, respectively.
- Amendment to 2021 Omnibus Incentive Plan approved, increasing authorized shares from 31,296 to 617,092 (202,246 for, 50,153 against).
- Ratification of Moss Adams LLP as independent auditor for FY 2023 approved with 1,631,139 votes for.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1716947/000149315223030391/0001493152-23-030391-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1716947/000149315223030391/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-23-030391

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer